What's new

Human medicines European public assessment report (EPAR): Axura, memantine, Date of authorisation: 17/05/2002, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Axura, memantine, Date of authorisation: 17/05/2002, Revision: 29, Status: Authorised

Jun 20, 2025 - 13:45
 0
Human medicines European public assessment report (EPAR): Axura, memantine, Date of authorisation: 17/05/2002, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Axura, memantine, Date of authorisation: 17/05/2002, Revision: 29, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Yorvipath, palopegteri...

Next Article

Virtual live hands-on training course for clinical trials sponsors using EudraVi...

Related Posts

Human medicines European public assessment report (EPAR): Velsipity, etrasimod, Date of authorisation: 16/02/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 17, 2025  0

Orphan designation: human decorin fused to the truncated homing peptide CRK Treatment of epidermolysis bullosa, 18/07/2022 Positive

Orphan designation: human decorin fused to the truncate...

Jun 5, 2025  0

Human medicines European public assessment report (EPAR): Cerdelga, eliglustat, Date of authorisation: 19/01/2015, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0